摘要
Management of patients with synchronous colorectal liver metastases(SCRLM)has transformed dramatically over the past 2 decades(1-3).A step-by-step,patient tailored approach as orchestrated by a multidisciplinary tumor board(MDT),combined with advances in surgical techniques,perioperative care and the evolution of systemic therapies have led to remarkable long-term outcomes(2,4).In particular,selected patients with resectable SCRLM undergoing surgery have been reported to enjoy 5-year survival rates as high as 76%(1).However,the optimal surgical strategy for these patients remains elusive with multiple retrospective studies presenting conflicting outcomes(4).In their up-to-date review of the literature Lillemoe and Vauthey sought to evaluate and critically appraise currently available surgical treatment strategies for patients presenting with SCRLM.
